Two Sigma Advisers LP Sells 1,293,400 Shares of DocuSign, Inc. (NASDAQ:DOCU)

Two Sigma Advisers LP trimmed its stake in DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 80.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 315,900 shares of the company's stock after selling 1,293,400 shares during the quarter. Two Sigma Advisers LP owned about 0.16% of DocuSign worth $28,412,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Park Avenue Securities LLC boosted its position in shares of DocuSign by 183.4% during the 4th quarter. Park Avenue Securities LLC now owns 10,558 shares of the company's stock worth $950,000 after purchasing an additional 6,832 shares in the last quarter. Ritholtz Wealth Management acquired a new position in DocuSign during the 4th quarter worth approximately $223,000. Merit Financial Group LLC raised its stake in DocuSign by 22.1% during the 4th quarter. Merit Financial Group LLC now owns 18,516 shares of the company's stock worth $1,665,000 after buying an additional 3,352 shares during the period. Ameritas Advisory Services LLC boosted its holdings in DocuSign by 2.5% in the fourth quarter. Ameritas Advisory Services LLC now owns 21,043 shares of the company's stock worth $1,893,000 after acquiring an additional 512 shares in the last quarter. Finally, UMB Bank n.a. grew its stake in DocuSign by 1,654.7% in the fourth quarter. UMB Bank n.a. now owns 930 shares of the company's stock valued at $84,000 after acquiring an additional 877 shares during the period. 77.64% of the stock is owned by institutional investors.

DocuSign Stock Performance

NASDAQ:DOCU opened at $89.73 on Wednesday. DocuSign, Inc. has a 52 week low of $48.70 and a 52 week high of $107.86. The firm has a 50-day moving average price of $81.71 and a two-hundred day moving average price of $85.48. The firm has a market cap of $18.17 billion, a price-to-earnings ratio of 18.50, a price-to-earnings-growth ratio of 6.94 and a beta of 1.21.

DocuSign (NASDAQ:DOCU - Get Free Report) last released its earnings results on Thursday, March 13th. The company reported $0.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.84 by $0.02. The company had revenue of $776.25 million during the quarter, compared to analyst estimates of $760.94 million. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. DocuSign's quarterly revenue was up 9.0% on a year-over-year basis. During the same period in the prior year, the company posted $0.76 earnings per share. As a group, sell-side analysts forecast that DocuSign, Inc. will post 1.17 earnings per share for the current year.

Insider Buying and Selling at DocuSign

In related news, insider James P. Shaughnessy sold 7,500 shares of DocuSign stock in a transaction that occurred on Tuesday, April 1st. The shares were sold at an average price of $81.31, for a total value of $609,825.00. Following the sale, the insider now owns 45,875 shares of the company's stock, valued at approximately $3,730,096.25. The trade was a 14.05% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Blake Jeffrey Grayson sold 16,111 shares of the company's stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $83.20, for a total value of $1,340,435.20. Following the completion of the transaction, the chief financial officer now owns 93,960 shares in the company, valued at approximately $7,817,472. The trade was a 14.64% decrease in their position. The disclosure for this sale can be found here. Insiders sold 47,851 shares of company stock worth $3,912,239 in the last quarter. 1.01% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several research firms have recently commented on DOCU. Morgan Stanley decreased their price objective on DocuSign from $97.00 to $92.00 and set an "equal weight" rating for the company in a report on Wednesday, April 16th. JMP Securities restated a "market outperform" rating and set a $124.00 price objective on shares of DocuSign in a report on Thursday, April 17th. UBS Group dropped their price objective on shares of DocuSign from $90.00 to $85.00 and set a "neutral" rating on the stock in a research note on Thursday, April 17th. HSBC raised shares of DocuSign from a "reduce" rating to a "hold" rating and set a $70.00 target price for the company in a research report on Friday, April 11th. Finally, Hsbc Global Res upgraded shares of DocuSign from a "moderate sell" rating to a "hold" rating in a report on Friday, April 11th. One analyst has rated the stock with a sell rating, eleven have assigned a hold rating and four have issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $92.46.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.